Keywords: update, sa, calls, data, bi, nevirapine, vertical
UPDATE - SA calls for more data with BI's nevirapine in vertical
Article | 19 July 2000
Following the furore surrounding Boehringer Ingelheim's offer to supplyits anti-HIV drug Viramune (nevirapine) free for five years to prevent mother-to-child ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
